Literature DB >> 26087934

Viral load of patients with hantavirus pulmonary syndrome in Argentina.

Carla María Bellomo1,2, Fanny Clara Pires-Marczeski1,2, Paula Julieta Padula1,2.   

Abstract

Hantavirus causes severe illness including pneumonia, which leads to hospitalization and often death. At present, there is no specific treatment available. The hantavirus pathogenesis is not well understood, but most likely both virus-mediated and host-mediated mechanisms, are involved. The aim of this study was to correlate viral load in samples of hantavirus pulmonary syndrome cases and hantavirus infected individuals, with clinical epidemiological parameters and disease outcome. The variables that could potentially be related with viral load were analyzed. The retrospective study included 73 cases or household contacts, with different clinical evolution. Viral load was measured by reverse-transcription and real time polymerase chain reaction. There was no statistically significant association between blood viral RNA levels and severity of disease. However, viral load was inversely correlated with IgG response in a statistically significant manner. The level of viral RNA was significantly higher in patients infected with Andes virus South lineage, and was markedly low in persons infected with Laguna Negra virus. These results suggest that the infecting viral genotype is associated with disease severity, and that high viral load is associated with a low specific IgG response. Sex, age and disease severity were not related with viral load. Further investigations increasing strikingly the number of cases and also limiting the variables to be studied are necessary.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Andes virus; Argentina; RNA load; Zoonosis; hantavirus; infectious disease; pediatrics; severity

Mesh:

Substances:

Year:  2015        PMID: 26087934     DOI: 10.1002/jmv.24260

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  6 in total

1.  Massive plasmablast response elicited in the acute phase of hantavirus pulmonary syndrome.

Authors:  Marina García; Ayelén Iglesias; Verónica I Landoni; Carla Bellomo; Agostina Bruno; María Teresa Córdoba; Luciana Balboa; Gabriela C Fernández; María Del Carmen Sasiain; Valeria P Martínez; Pablo Schierloh
Journal:  Immunology       Date:  2017-02-09       Impact factor: 7.397

Review 2.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

3.  Hantavirus Infection Suppresses Thrombospondin-1 Expression in Cultured Endothelial Cells in a Strain-Specific Manner.

Authors:  Svetlana F Khaiboullina; Sergey P Morzunov; Stephen C St Jeor; Albert A Rizvanov; Vincent C Lombardi
Journal:  Front Microbiol       Date:  2016-07-19       Impact factor: 5.640

4.  Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana.

Authors:  Séverine Matheus; Hatem Kallel; Alexandre Roux; Laetitia Bremand; Bhety Labeau; David Moua; Dominique Rousset; Damien Donato; Vincent Lacoste; Stéphanie Houcke; Claire Mayence; Benoît de Thoisy; Didier Hommel; Anne Lavergne
Journal:  Emerg Infect Dis       Date:  2018-09       Impact factor: 6.883

5.  Emerging hantaviruses in Central Argentina: First case of Hantavirus Pulmonary Syndrome caused by Alto Paraguay virus, and a novel orthohantavirus in Scapteromys aquaticus rodent.

Authors:  Carla Bellomo; Daniel Oscar Alonso; Tamara Ricardo; Rocío Coelho; Sebastián Kehl; Natalia Periolo; Viviana Azogaray; Natalia Casas; Mariano Ottonelli; Laura Cristina Bergero; María Carolina Cudós; María Andrea Previtali; Valeria Paula Martinez
Journal:  PLoS Negl Trop Dis       Date:  2021-11-17

Review 6.  Hantavirus Cardiopulmonary Syndrome Due to Imported Andes Hantavirus Infection in Switzerland: A Multidisciplinary Challenge, Two Cases and a Literature Review.

Authors:  Andrea B Kuenzli; Jonas Marschall; Joerg C Schefold; Margaret Schafer; Oliver B Engler; Rahel Ackermann-Gäumann; David C Reineke; Franziska Suter-Riniker; Cornelia Staehelin
Journal:  Clin Infect Dis       Date:  2018-11-13       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.